Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience

N Wilson1, P Heaton, L Calder

  • 1Paediatric Cardiology, Green Lane Hospital, Auckland 1030, New Zealand. nigelw@adhb.got.nz

Insights

Delayed diagnosis of Kawasaki disease (KD) in children increases cardiac risks. Early treatment with intravenous immunoglobulin (IVIG) is crucial for preventing severe coronary artery complications and improving outcomes.

Area of Science:

  • Pediatrics
  • Cardiology
  • Immunology

Background:

  • Kawasaki disease (KD) is a significant cause of acquired heart disease in children.
  • Intravenous immunoglobulin (IVIG) is the standard treatment to prevent coronary artery aneurysms.
  • Timely administration of IVIG (within 8-10 days of onset) is critical for efficacy.

Purpose of the Study:

  • To review recent cases of Kawasaki disease (KD) with severe cardiac complications in New Zealand.
  • To highlight the impact of diagnostic delays on treatment outcomes and patient prognosis.

Main Methods:

  • Retrospective analysis of six pediatric cases of KD with significant coronary artery sequelae.
  • Review of clinical course, diagnostic criteria, laboratory results, and cardiac findings.

Main Results:

  • Three of six children experienced diagnostic delays, impacting treatment.
  • All six patients exhibited significant coronary artery involvement, including aneurysms and thrombi.
  • Three children died due to cardiac complications, including aneurysm rupture and coronary artery obstruction.

Conclusions:

  • Kawasaki disease continues to pose a substantial risk of mortality and morbidity in children.
  • Diagnostic delays beyond 8 days significantly diminish the effectiveness of IVIG therapy.
  • Further epidemiological studies are needed to understand KD prevalence in New Zealand.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...